6,544 followers
New research: Real-World Lenvatinib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis: Background Lenvatinib is approved for patients with advanced hepatocellular carcinoma (HCC) due to… https://t.co/